GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Summary

The protocol aims at adding GRASPA (L-asparaginase encapsulated in red blood cells, eryaspase) to standard chemotherapy (low-dose cytarabine) to treat patients older than 65 years diagnosed with AML and unfit for intensive chemotherapy.

Timeline

Start

2013-02

Primary completion

2017-11-10

Completion

2017-11-10

Drugs

Indications